Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists - ScienceDirect

European Journal of Cancer

Volume 87, December 2017, Page 204

European Journal of Cancer

https://doi.org/10.1016/j.ejca.2017.06.042 Get rights and content

Section snippets

Conflict of interest statement

None declared.

References (3)

P.C. Albertsen
Re: Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists
Eur J Cancer
(2017)

There are more references available in the full text version of this article.

Cited by (1)

Do gonadotropin-releasing hormone antagonists have a lower risk of cardiovascular complications in comparison to agonists?
2018, Cardiology Letters

© 2017 Elsevier Ltd. All rights reserved.